Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients

Clinica Chimica Acta

Volumn 408, Issue 1-2, 2009, Pages 105-109

  Gai, Xiaobo ^a   Lan, Xiaopeng ^a   Luo, Zhurong ^a   Wang, Feifei ^b   Liang, Yonggang ^a   Zhang, Hueimin ^a   Zhang, Wenli ^a   Hou, Jianping ^a   Huang, Mingfang ^a  

^a FUZHOU GENERAL HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Gene polymorphism; Hypertensive heart disease; MMP 9

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE B;

AGED; ARTICLE; CHINESE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HOMOZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEART DISEASES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MATRIX METALLOPROTEINASE 9; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 69849085775     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.07.020     Document Type: Article

References (30)

1. Kannel W.B., Wolf P.A., Benjamin E.J., et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82 (1998) 2N-9N
2. Casaclang-Verzosa G., Gersh B.J., and Tsang T.S. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 51 (2008) 1-11
3. Li D., Fareh S., Leung T.K., et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100 (1999) 87-95
4. Anne W., Willems R., Holemans P., et al. Self-terminating AF depends on electrical remodeling while persistent AF depends on additional structural changes in a rapid atrially paced sheep model. J Mol Cell Cardiol 43 (2007) 148-158
5. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87 (2007) 1285-1342
6. Nakano Y., Niida S., Dote K., et al. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coll Cardiol 43 (2004) 818-825
7. Mukherjee R., Herron A.R., Lowry A.S., et al. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol 97 (2006) 532-537
8. Polyakova V., Miyagawa S., Szalay Z., et al. Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med 12 (2008) 189-208
9. Chen C.L., Huang S.K., Lin J.L., et al. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation. J Mol Cell Cardiol 45 (2008) 742-753
10. Moe G.W., Laurent G., Doumanovskaia L., et al. Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure. J Card Fail 14 (2008) 768-776
11. Zhang B., Henney A., Eriksson P., et al. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 105 (1999) 418-423
12. Verdecchia P., Reboldi G., Gattobigio R., et al. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 41 (2003) 218-223
13. Kistler P.M., Sanders P., Dodic M., et al. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J 27 (2006) 3045-3056
14. Choisy S.C., Arberry L.A., Hancox J.C., et al. Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts. Hypertension 49 (2007) 498-505
15. Liu F., Levin M.D., Petrenko N.B., et al. Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. J Mol Cell Cardiol 45 (2008) 715-723
16. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
17. Koren M.J., Devereux R.B., Casale P.N., et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114 (1991) 345-352
18. Huang M., Gai X., Yang X., et al. Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease. Clin Chem Lab Med 47 (2009) 32-37
19. Zhang B., Ye S., Herrmann S.M., et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99 (1999) 1788-1794
20. Hu Z., Huo X., Lu D., et al. Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer. Clin Cancer Res 11 (2005) 5433-5439
21. Fox C.S., Parise H., D'Agostino R.B., et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 291 (2004) 2851-2855
22. Arnar D.O., Thorvaldsson S., Manolio T.A., et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 27 (2006) 708-712
23. Darbar D. Genetics of atrial fibrillation: rare mutations, common polymorphisms, and clinical relevance. Heart Rhythm 5 (2008) 483-486
24. Nyberg M.T., Stoevring B., Behr E.R., et al. The variation of the sarcolipin gene (SLN) in atrial fibrillation, long QT syndrome and sudden arrhythmic death syndrome. Clin Chim Acta 375 (2007) 87-91
25. Fatini C., Sticchi E., Genuardi M., et al. Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation. Eur Heart J 27 (2006) 1712-1718
26. Tsai C.T., Lai L.P., Lin J.L., et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109 (2004) 1640-1646
27. Ravn L.S., Benn M., Nordestgaard B.G., et al. Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population. Pharmacogenet Genomics 18 (2008) 525-533
28. Heckbert S.R., Wiggins K.L., Glazer N.L., et al. Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population. Am J Hypertens 22 (2009) 538-544
29. Blankenberg S., Rupprecht H.J., Poirier O., et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107 (2003) 1579-1585
30. Yasmin, McEniery C.M., O'Shaughnessy K.M., et al. Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals. Arterioscler Thromb Vasc Biol 26 (2006) 1799-1805